News
-
Commonly prescribed antihistamine is linked with elevated rates of tic, anxiety, and conduct disorders in children
Hydroxyzine is a first-generation antihistamine commonly prescribed in syrup form to infants and young children with itch-inducing skin conditions, such as atopic dermatitis and eczema. New research shows that the more hydroxyzine a child is prescribed, the higher their risk for developing a tic, anxiety, or conduct disorder.
-
BC Children’s Hospital researchers part of international collaboration to develop treatments for osteosarcoma
BC Children’s Hospital researchers are part of a new international collaboration aimed at developing innovative treatments for osteosarcoma — a highly malignant bone cancer that commonly affects children and adolescents.
-
Congratulations CIHR Spring 2022 Project Grant recipients
Congratulations to the BC Children’s Hospital Research Institute (BCCHR) and Women’s Health Research Institute (WHRI) investigators and their teams who were awarded funding through the Canadian Institutes of Health Research (CIHR) Spring 2022 Project Grant competition. Our research community received around $15 million in new research grants as principal investigators or co-investigators.
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.
for media